Friday, July 31, 2026

North Korean Hackers Impersonate Microsoft Security Team in New Malware Campaign

A North Korean hacking group APT37 has launched a malware campaign disguised as Microsoft alerts, targeting South Korean users.

Are Your Biotech Stocks Safe? New KOSDAQ Regulations Could Mean Trouble for 21 Companies

KOSDAQ's delisting rules tighten with new market cap thresholds, impacting biotech firms. Stricter criteria may challenge innovation.

Ku Klux Klan: How White Supremacy Took Root in Post-Civil War America

The KKK, founded in 1865, is a white supremacist group that used violence to intimidate minorities and influence politics in America.

Tag: Zymfentra

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Celltrion’s Zymfentra Just Hit a New U.S. Prescription Record and the Growth Looks Serious

Celltrion's Zymfentra treatment saw a 185% surge in U.S. prescriptions, driven by effective marketing and reimbursement strategies.

How Celltrion’s Local Production Strategy Eliminates U.S. Drug Tariffs Influence

Celltrion resolves tariff impacts on U.S. sales, boosting local production and growth opportunities for its biosimilars, including Zymfentra.

How Zymfentra’s Prescription Rates Tripled in January: A Game-Changer for Celltrion

Celltrion's Zymfentra sees a 213% rise in U.S. prescriptions, marking significant growth since its launch, driven by market demand.

Celltrion’s Zymfentra: How This Breakthrough Drug is Driving Record Sales

Celltrion expects record sales driven by Zymfentra's success, expanding into new biosimilars and CDMO business for future growth.

K-Bio Targets the U.S. Market: Celltrion and Samsung Bioepis Close in on Originator Drugs

Celltrion and Samsung Bioepis are expanding in the U.S. market, showing strong growth in biosimilars like Zymfentra and Hadlima.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.